Charles Schwab Investment Management Inc Affimed N.V. Transaction History

Charles Schwab Investment Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $9,446 - $21,040	8,588 Added 2.7%	326,086 $404,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $9,856 - $16,696	5,029 Added 1.61%	317,498 $655,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $122,757 - $262,819	54,078 Added 20.93%	312,469 $866,000
Q1 2022 May 13, 2022	SELL	$3.69 - $5.65 $279,484 - $427,936	-75,741 Reduced 22.67%	258,391 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$5.37 - $7.07 $26,291 - $34,614	4,896 Added 1.49%	334,132 $1.85 Million
Q3 2021 Nov 16, 2021	SELL	$5.54 - $7.51 $257,089 - $348,509	-46,406 Reduced 12.35%	329,236 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $56,436 - $82,695	7,254 Added 1.97%	375,642 $3.19 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $324,280 - $537,089	63,336 Added 20.76%	368,388 $2.91 Million
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $27,172 - $60,450	8,599 Added 2.9%	305,052 $1.78 Million
Q3 2020 Nov 13, 2020	SELL	$3.26 - $4.73 $148,590 - $215,593	-45,580 Reduced 13.33%	296,453 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $7,520 - $22,038	4,760 Added 1.41%	342,033 $1.58 Million
Q4 2019 Feb 07, 2020	BUY	$2.25 - $3.07 $69,592 - $94,955	30,930 Added 10.1%	337,273 $925,000
Q3 2019 Nov 08, 2019	BUY	$2.67 - $3.65 $483,136 - $660,467	180,950 Added 144.31%	306,343 $901,000
Q2 2019 Aug 09, 2019	BUY	$2.6 - $4.21 $326,021 - $527,904	125,393 New	125,393 $360,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.